Chenwei Medical Showcases Anesthesia and Critical Care Technologies
Posted on 18 Nov 2026
Chenwei Medical (Nanjing, China) is showcasing its anesthesia and respiratory support technologies at MEDICA 2026, taking place November 16–19 in Düsseldorf, Germany. At Hall 11, Stand 11D08, the company is highlighting its M9 Anesthesia Workstation, T80 ICU Ventilator, and CWH-2020 Emergency & Transport Ventilator. These systems are designed to support anesthesia management, intensive care ventilation, and respiratory support during emergency patient transport.
Among the featured products is the M9 Anesthesia Workstation, which incorporates electronic gas mixing and a virtual flowmeter display to support precise gas delivery and control. The system features an Eco Flow low-flow anesthesia assistant, along with anesthetic gas and anesthesia depth monitoring capabilities. Its compact breathing system incorporates a bypass function to support anesthesia workflows.
Chenwei is also presenting the T80 ICU Ventilator, designed for adult, pediatric, and neonatal patients. The system features a turbine capable of delivering peak flow rates of up to 210 L/min and supports advanced ventilation modes and high-flow oxygen therapy at rates of up to 80 L/min. It also incorporates a dynamic lung view, real-time waveform analysis, and 96-hour trend review to support respiratory monitoring and clinical decision-making in intensive care settings.
Another featured product is the CWH-2020 Emergency & Transport Ventilator, which supports invasive and non-invasive ventilation during patient transport. Weighing less than 4 kg for the main unit, the device incorporates a 90-degree rotating quick-release mounting bracket for flexible installation. It offers up to six hours of battery operation and supports 12V DC vehicle power, allowing ventilation to continue during transport.
As part of its MEDICA 2026 participation, Chenwei Medical is also hosting LinkedIn Live sessions featuring demonstrations of the three systems and discussions with clinical and product experts. The sessions take place November 16–18, providing additional opportunities to examine the company's anesthesia and critical care technologies.